This book provides a detailed survey of the emotional, behavioural and cognitive disorders prevalent among patients with Multiple Sclerosis (MS), including depression, mania, psychosis, pathological laughing and crying, and cognitive dysfunction. Attention has tended to focus on the physical aspects of MS, the commonest source of neurological disability in young and middle-aged adults, but recognition and treatment of the behavioural changes associated with the disease can be equally important in improving quality of life for the patient. For each of the neuropsychiatric disorders associated with MS, clear clinical guidelines are given for diagnosis and treatment, there is a detailed review of the literature, and case vignettes are incorporated. There are chapters on screening and neuroimaging and a final chapter examines the broader concept of subcortical white matter dementia. This book will be of interest to psychiatrists, neurologists, psychologists, nurses and other professionals involved in the management of patients with MS.

Textbook of Clinical Neuropsychiatry provides a comprehensive, encyclopedic and up to date coverage of the complete range of neuropsychiatric disorders. The text is clearly written and well organized, utilizing a consistent and easy to read format throughout. Part I describes the diagnostic assessment of patients and details the interview, mental s

Multiple sclerosis is the most common cause of neurological disability in young and middle-aged adults. This fully updated and revised new edition provides a detailed account of the many neuropsychiatric disorders associated with MS and is relevant to both the research and the clinical setting. Using the latest brain imaging findings and results from treatment trials, the symptoms, assessment, diagnosis, and treatment of depression in MS are covered, as are psychosocial factors and the link between depression and MRI abnormalities. Subsequent chapters focus on cognitive dysfunction in MS, including the natural history of cognitive change, the use of screening instruments and neuropsychological batteries, brain imaging correlations and management strategies. The book concludes with a survey of the behavioral benefits and risks associated with disease-modifying drugs. It will be valuable to all mental health professionals, neurologists, and others caring for those affected by MS.

A unique resource for all health care practitioners caring for people with multiple sclerosis. Endorsed by The Consortium of Multiple Sclerosis Centers Multiple sclerosis (MS), a progressive neurologic disease, is characterized by a host of physical symptoms. But the neurobehavioral consequences of MS can be as devastating and debilitating as physical symptoms, and they are often unreported and undertreated. In this new book, Dr. Anthony Feinstein, a neuropsychiatrist, documents the effects of MS on cognition, information processing speed, learning and memory, executive function, personality, mood, and behavior. Feinstein touches on a number of topics, including • the common cognitive challenges that occur with MS, such as slowed information processing speed, impaired memory, and executive function deficits • psychiatric disorders that accompany MS, such as depression and psychosis • current neuropsychological, brain MRI, and treatment data applicable to the psychiatric and cognitive disorders Mind, Mood, and Memory in Multiple Sclerosis is enhanced both by the latest science and by eloquent case histories that illustrate each cognitive and emotional disorder. Feinstein also provides recommendations for evidence-based therapeutic interventions. Written in an immediate, accessible way, this book has a crossover appeal, making it of interest not only to neurologists, psychiatrists, neuropsychiatrists, neuropsychologists, psychologists, occupational therapists, and nurses but also to people with MS and their caregivers, family, and friends.

Presents a practical and accessible approach to the diagnosis and management of multiple sclerosis in hospital and outpatient settings.

This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. The status of the rapidly evolving field of disease-modifying drugs is presented, with emphasis on the most promising therapies currently being tested. Experts discuss disease and symptom management for MS subtypes, including neuromyelitis optica and pediatric MS. In addition, key scientific advances in MS pathology, genetics, immunology and epidemiology are presented. The fourth edition has been extensively revised, featuring more than 50% new material. All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. This book is an essential reference for practitioners caring for MS patients, investigators planning or conducting clinical trials, and clinical trial sponsors.

Multiple sclerosis is a chronic and often disabling disease of the nervous system, affecting about 1 million people worldwide. Even though it has been known for over a hundred years, no cause or cure has yet been discovered-but now there is hope. New therapies have been shown to slow the disease progress in some patients, and the pace of discoveries about the cellular machinery of the brain and spinal cord has accelerated. This book presents a comprehensive overview of multiple sclerosis today, as researchers seek to understand its processes, develop therapies that will slow or halt the disease and perhaps repair damage, offer relief for specific symptoms, and improve the abilities of MS patients to function in their daily lives. The panel reviews existing knowledge and identifies key research questions, focusing on: Research strategies that have the greatest potential to understand the biological mechanisms of recovery and to translate findings into specific strategies for therapy. How people adapt to MS and the research needed to improve the lives of people with MS. Management of disease symptoms (cognitive impairment, depression, spasticity, vision problems, and others). The committee also discusses ways to build and financially support the MS research enterprise, including a look at challenges inherent in designing clinical trials. This book will be important to MS researchers, research funders, health care advocates for MS research and treatment, and interested patients and their families.

Quantitative Magnetic Resonance Imaging is a 'go-to' reference for methods and applications of quantitative magnetic resonance imaging, with specific sections on Relaxometry, Perfusion, and Diffusion. Each section will start with an explanation of the basic techniques for mapping the tissue property in question, including a description of the challenges that arise when using these basic approaches. For properties which can be measured in multiple ways, each of these basic methods will be described in separate chapters. Following the basics, a chapter in each section presents more advanced and recently proposed techniques for quantitative tissue property mapping, with a concluding chapter on clinical applications. The reader will learn: - The basic physics behind tissue property mapping - How to implement basic pulse sequences for the quantitative measurement of tissue properties - The strengths and limitations to the basic and more rapid methods for mapping the magnetic relaxation properties T1, T2, and T2* - The pros and cons for different approaches to mapping perfusion - The methods of Diffusion-weighted imaging and how this approach can be used to generate diffusion tensor - maps and more complex representations of diffusion - How flow, magneto-electric tissue property, fat fraction, exchange, elastography, and temperature mapping are performed - How fast imaging approaches including parallel imaging, compressed sensing, and Magnetic Resonance - Fingerprinting can be used to accelerate or improve tissue property mapping schemes - How tissue property mapping is used clinically in different organs - Structured to cater for MRI researchers and graduate students with a wide variety of backgrounds - Explains basic methods for quantitatively measuring tissue properties with MRI - including T1, T2, perfusion, diffusion, fat and iron fraction, elastography, flow, susceptibility - enabling the implementation of pulse sequences to perform measurements - Shows the limitations of the techniques and explains the challenges to the clinical adoption of these traditional methods, presenting the latest research in rapid quantitative imaging which has the possibility to tackle these challenges - Each section contains a chapter explaining the basics of novel ideas for quantitative mapping, such as compressed sensing and Magnetic Resonance Fingerprinting-based approaches

An overview of important current subjects in old age psychiatry, demonstrating the depth and breadth of the speciality.

This handbook is a collection of clinical narratives that underscore the heterogeneous and unpredictable presentation of multiple sclerosis (MS) and give real-world clinical context to recent drug developments. This accessible and concise publication is intended to be used by a wide range of medical professionals, from specialist neurologists to medical trainees with an interest in neurology. An ideal clinical resource, Case Studies in Multiple Sclerosis provides an evidence-based discussion of each case, with an aim to enhance effective diagnosis and treatment of patients with MS and MS-related conditions.